enGene Holdings Inc. Warrants
NASDAQ Capital MarketTotal Valuation
enGene Holdings Inc. Warrants carries a market capitalization of 14.34M, placing it among publicly traded companies globally. Its enterprise value stands at -225.11M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 14.34M |
| Enterprise Value | -225.11M |
Share Statistics
enGene Holdings Inc. Warrants currently has 66.99M shares outstanding.
| Shares Outstanding | 66.99M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
enGene Holdings Inc. Warrants maintains a current ratio of 12.57, meaning it holds 12.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 13.07, indicating elevated leverage, while an interest coverage ratio of -44.19 demonstrates limited ability to service its debt obligations.
| Current Ratio | 12.57 |
| Quick Ratio | 12.07 |
| Debt / Equity | 13.07 |
| Debt / EBITDA | -0.25 |
| Interest Coverage | -44.19 |
Financial Efficiency
| Return on Equity (ROE) | -62.65 |
| Return on Assets (ROA) | -44.19 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
| Income Tax | -258,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
enGene Holdings Inc. Warrants's stock has declined approximately -62.14865% over the past 52 weeks. The 50-day moving average sits at 0.81, while the 200-day moving average is 1.99.
| Beta (5Y) | N/A |
| 52-Week Price Change | -62.14865% |
| 50-Day Moving Average | 0.81 |
| 200-Day Moving Average | 1.99 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -131.91M, while operating income came in at -132.58M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -132.58M |
| Pretax Income | -127.11M |
| Net Income | -126.85M |
| EBITDA | -131.91M |
| EBIT | -132.58M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
enGene Holdings Inc. Warrants holds 258.47M in cash and equivalents against 33.35M in total debt, resulting in a net debt position of -4.72M. Total book value stands at 199.98M, with working capital of 248.52M providing operational flexibility.
| Cash & Cash Equivalents | 258.47M |
| Total Debt | 33.35M |
| Net Debt | -4.72M |
| Equity (Book Value) | 199.98M |
| Book Value Per Share | N/A |
| Working Capital | 248.52M |
Cash Flow
enGene Holdings Inc. Warrants produced -110.00M in operating cash flow over the past twelve months.
| Operating Cash Flow | -110.00M |
| Capital Expenditures | -1.39M |
| Free Cash Flow | -111.39M |
| FCF Per Share | N/A |
Scores
enGene Holdings Inc. Warrants posts an Altman Z-Score of -2.42, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -2.42 |